Andelyn Partners With Celliaz on Retinitis Gene Therapy
Columbus, Ohio, USA, November 12, 2026 Andelyn Biosciences has announced a strategic partnership with South Korean biotechnology company Celliaz...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease solid tumors targeted therapy
Columbus, Ohio, USA, November 12, 2026 Andelyn Biosciences has announced a strategic partnership with South Korean biotechnology company Celliaz...
León, Spain, November 9, 2026 Curia Global, Inc., a global contract research, development and manufacturing organization (CDMO), has announced...
Copenhagen, Denmark, November 3, 2026 AGC Biologics has expanded its long-term manufacturing partnership with an unnamed global pharmaceutical company...
Darmstadt, Germany, November 3, 2026 Merck KGaA has signed a definitive agreement to divest its Contract Development and Manufacturing...
HANGZHOU, China, October 29, 2026 Altruist Biologics, a contract development and manufacturing organization (CDMO) and wholly owned subsidiary of...
TIANJIN, China, October 29, 2026 Asymchem has successfully completed its first U.S. Food and Drug Administration (USFDA) Pre-Approval Inspection...
CAMBRIDGE, UK — September 28, 2026 4basebio PLC announced a collaboration with TriLink BioTechnologies, part of Maravai LifeSciences, to...
Heidelberg, Germany, September 24, 2026 Flen Health has selected AGC Biologics as its contract development and manufacturing organization (CDMO)...
GEORGETOWN, Texas — September 15, 2026 AustinPx announced that the U.S. Food and Drug Administration’s Center for Drug Evaluation...
LAVAL, Québec — September 24, 2026 Altasciences announced that its formulation development, manufacturing and quality support for 4B Healthcare...
